Ensysce Biosciences Submits Phase 3 Protocol to the FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Ensysce Biosciences Submits Phase 3 Protocol to the FDA
(NASDAQ: ENSC) Delayed: 0.40 +0.05 (14.29%)
Previous Close $0.35    52 Week High $ 
Open $0.34    52 Week Low $ 
Day High $0.47    P/E N/A 
Day Low $0.33    EPS $ 
Volume 18,691,527